HIV-1 T-cell vaccines: evaluating the next step (Q64376882)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060842%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

HIV-1 T-cell vaccines: evaluating the next step (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060842%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Giuseppe Pantaleo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060842%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

3 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060842%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060842%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060842%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060842%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

82-83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060842%20AND%20SRC:MED&resulttype=core&format=json

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970266-9

7 January 2021

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970266-9

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970266-9

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970266-9

7 January 2021

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970266-9

7 January 2021

Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970266-9

7 January 2021

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970266-9

7 January 2021

Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970266-9

7 January 2021

Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970266-9

7 January 2021

10.1016/S1473-3099(07)70266-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18060842%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference